Clin2
NCT06662942Possibly a fitRecruiting

Testing StrataMGT for vulvar lichen sclerosus symptoms

Vulvar Lichen Sclerosus

Part of Women’s health & pregnancy clinical trials.

This study tests whether a new topical treatment, StrataMGT, can reduce symptoms of vulvar lichen sclerosus. It is for women with moderate to severe symptoms who are already using a stable topical prescription.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are female and 18 years or older.
  • You have a confirmed diagnosis of vulvar lichen sclerosus by biopsy.
  • You have moderate to severe LS symptoms (score of 10 or more on a special symptom questionnaire).
  • You have been using a stable dose of a topical steroid or calcineurin inhibitor for at least 2 months.
  • You do not have other serious skin conditions like lichen planus, psoriasis, or vulvar cancer.
  • You do not have an active infection (bacterial or yeast) at screening.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07352917Recruiting· Phase 2
Methotrexate for severe vulvar lichen sclerosus

This study tests the drug methotrexate as a treatment for severe vulvar lichen sclerosus that has not responded to strong steroid creams. It aims to see if methotrexate can reduce symptoms and prevent further scarring.

São José dos Campos, São Paulo
NCT07240389Not yet recruiting
Comparing three treatments for vulvar lichen sclerosus

This study compares three different treatments for vulvar lichen sclerosus (a skin condition that can cause itching and pain in the vulvar area): a steroid ointment, a calcineurin inhibitor ointment, and platelet-rich plasma (PRP) therapy. It aims to see which treatment works best to relieve symptoms.

Krakow, Małopolska
NCT07363733Recruiting
Comparing radiofrequency vs steroid cream for vulvar lichen sclerosus

This study compares a new non-invasive treatment using radiofrequency energy to a standard steroid cream for women with vulvar lichen sclerosus. The goal is to see which works better for symptom relief.

Moscow
NCT07240519Recruiting
Comparing clobetasol cream vs CO2 laser for vulvar lichen sclerosus

This study compares two treatments—clobetasol steroid cream or a fractional CO2 laser—for women with vulvar lichen sclerosus who have not used steroid cream before. It looks at how inflammation changes after treatment.

Rio de Janeiro, Rio de Janeiro
NCT07450625Not yet recruiting
Collagen supplement for vulvar dryness in lichen sclerosus

This study tests whether a supplement called Collagendep (which contains collagen and hyaluronic acid) can help reduce dryness in women with lichen sclerosus who are also having a fat grafting procedure. It aims to see if adding this supplement improves symptoms compared to the fat grafting alone.

NCT06389071Recruiting
Laser treatment for lichen sclerosus

This study tests a laser treatment for women with vulvar lichen sclerosus to see if it can help with symptoms like itching, burning, pain, or soreness. It's a option for those who have had a biopsy to confirm the condition.

Val-d'Or, Quebec

Hear when a new Vulvar Lichen Sclerosus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.